Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Jacobs

Vascular & Interventional Radiology Murray, UT Medical Doctor

NPI 1912947995 CMS profile 86362

5444 Green St, Murray, UT 84123

Open in the dashboard

General payments

$67,690

82 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Jacobs of Murray, UT is reported in the CMS Open Payments database as having received $67,690 across 82 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20 1
2024 General $17 1
2023 General $261 4
2022 General $8,229 10
2021 General $2,492 4
2020 General $4,760 3
2019 General $51,911 59

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Jacobs
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to John Jacobs were reported at $20. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year John Jacobs Vascular & Interventional Radiology median Middle half National median
2019 $51,911 $422 $125–$1,555 $163
2020 $4,760 $200 $68–$652 $114
2021 $2,492 $280 $99–$866 $132
2022 $8,229 $433 $137–$1,497 $149
2023 $261 $506 $152–$2,019 $160
2024 $17 $556 $175–$1,930 $164
2025 $20 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cook Incorporated $59,190 17 payments
  2. Cook Medical LLC $4,587 43 payments
  3. Merit Medical Systems Inc $2,869 4 payments
  4. Penumbra, Inc. $358 3 payments
  5. Stryker Corporation $218 5 payments
  6. DePuy Synthes Sales Inc. $173 2 payments
  7. Scientia Vascular $127 3 payments
  8. Boston Scientific Corporation $89 1 payment
  9. Medtronic, Inc. $27 1 payment
  10. Novo Nordisk Inc $20 1 payment
  11. Other $32 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $51,855 11 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,930 1 payment
  3. Food and Beverage $3,144 51 payments
  4. Travel and Lodging $2,892 15 payments
  5. Consulting Fee $2,869 4 payments
Products named General payments · program years 2019–2025
  1. Cook Medical IAA $18,720 6 payments
  2. Cook Medical Filters $17,937 15 payments
  3. Cook Medical Celect Platinum $9,652 3 payments
  4. Cook Medical Gunther Tulip $7,880 17 payments
  5. Cook Celect $7,564 4 payments
  6. Cook Medical Peripheral Intervention $1,469 11 payments
  7. Cook Medical Zilver PTX $388 1 payment
  8. Penumbra System $220 2 payments
  9. RED 72 $139 1 payment
  10. EMBOTRAP $125 1 payment
  11. Other $555 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Diagnostic Radiology: 24

Drug cost

$39

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diazepam Generic 12 $39

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 126 billing codes

Paid by Medicare

$173,353

Medicare's payments for the services billed

Medicare patients

3,444

Average age 75

Services billed

5,346

1,940 women, 1,504 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Chronic kidney disease 38%
Depression 37%
Diabetes 35%
Ischemic heart disease 35%
Heart failure 27%
Atrial fibrillation 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

82 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record